The case-patient was a 55-year-old man with a history of diabetes, hypertension, arthritis, pulmonary disease, peripheral vascular disease, methicillin-resistant S aureus (MRSA), and ... use or ...

The mean MRSA incidence density was 0.094 (SD±0.047), the mean ... diseases could also require standard hygienic precautions such as the use of personal protective equipment. This consideration would ...

The case-patient was a 55-year-old man with a history of diabetes, hypertension, arthritis, pulmonary disease, peripheral vascular disease, methicillin-resistant S aureus (MRSA), and ... use or ...

MRSA does pose a threat to children ... If you are a rescuer, practice universal precautions and wear personal protective equipment if available. Stay away from dogs you do not know. If a stray dog ...

MRSA is a type of staph highly resistant to a common class of antibiotics. Many people carry MRSA harmlessly on their skin or inside their noses. However, if the bacteria penetrates the skin, it ...

Effective December 12, 2024, the Occupational Safety and Health Administration (OSHA) finalized an update to its personal ...

OSHA has finalized changes to its PPE standard for the construction industry, requiring all PPE properly fit workers who need it. The updated rule addresses long-standing concerns about ill ...

The U.S. Dept. of Labor announced Dec. 11 that its Occupational Safety and Health Administration has finalized a revision to the personal protective equipment standard for construction.

Abstract: Methicillin-resistant S. aureus (MRSA) has prominently emerged among the recognized causes of community-acquired and hospital infections. We proposed a novel computational approach, ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins Some states have laws and ethical rules regarding solicitation and ...

HY-133 is under clinical development by HyPharm and currently in Phase I for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. According to GlobalData, Phase I drugs for ...

aureus, including hard-to-treat infections caused by methicillin-resistant strains (MRSA), said Basilea. Ceftobiprole was turned down by the FDA in 2009 for ABSSSI, when the drug was partnered ...